Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Pared Trial of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® in the Chronic Hepatitis B Patients on the Clinical Stability .( Aged 30 Years or Over)

NCT02964910 is registered in ClinicalTrials.gov with Xiamen Innovax Biotech Co., Ltd as lead sponsor.

NCT NCT02964910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Pared Trial of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® in the Chronic Hepatitis B Patients on the Clinical Stability .( Aged 30 Years or Over)
Lead sponsor
Xiamen Innovax Biotech Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2016
Completion date
December 31, 2017
Enrollment
475 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis e